EuropeanJournalofCardio-ThoracicSurgery44(2013)e260–e265 ORIGINALARTICLE
doi:10.1093/ejcts/ezt375 AdvanceAccesspublication26July2013
High-intensity training and cardiopulmonary exercise testing
in patients with chronic obstructive pulmonary disease and
non-small-cell lung cancer undergoing lobectomy
FrancescoStefanellia,IlernandoMeolia,RaffaeleCobuccioa,*,CarloCurciob,DarioAmoreb,DinoCasazzab,
MauraTraceycandGaetanoRoccoc
a DivisionofPneumology,AORNDeiColli‘MonaldiHospital’,Naples,Italy
b DivisionofThoracicSurgery,AORNDeiColli‘MonaldiHospital’,Naples,Italy
c DivisionofThoracicSurgery,IstitutoNazionaledeiTumori‘PascaleFoundation’,Naples,Italy
* Correspondingauthor.Tel:+39-817064179;fax:+39-817064382;e-mail:raffaelecobuccio@hotmail.com(R.Cobuccio).
Received18February2013;receivedinrevisedform25May2013;accepted11June2013
Abstract
OBJECTIVES: Peak VO , as measure of physical performance is central to acorrect preoperative evaluation in patients with both non-
2
small-celllungcancer(NSCLC)andchronicobstructivepulmonarydisease(COPD)becauseitiscloselyrelatedbothtooperabilitycriteria
and the rate of postoperative complications. Strategies to improve peak VO , as a preoperative pulmonary rehabilitation programme
2
(PRP),shouldbeconsideredfavourablyinthesepatients.Inordertoclarifytheroleofpulmonaryrehabilitation,wehaveevaluatedthe
effectsof3-weekpreoperativehigh-intensitytrainingonphysicalperformanceandrespiratoryfunctioninagroupofpatientswithboth
NSCLCandCOPDwhounderwentlobectomy.
METHODS: We studied 40 patients with both NSCLC and COPD, age<75 years, TNM stages I–II, who underwent lobectomy. Patients
wererandomlydividedintotwogroups(RandS):GroupRunderwentanintensivepreoperativePRP,whileGroupSunderwentonlylob-
ectomy.WeevaluatedpeakVO inallpatientsatTime0(T0),afterPRP/beforesurgeryinGroupR/S(T1)and60daysaftersurgery,respect-
2
ively,inbothgroups(T2).
RESULTS:TherewasnodifferencebetweengroupsinpeakVO atT0,whileasignificantdifferencewasobservedbothatT1andT2.In
2
GroupR,peakVO improvessignificantlyfromT0toT1:14.9±2.3–17.8±2.1ml/kg/min± standarddeviation(SD),P<0.001(64.5±16.5–
2
76.1±14.9% predicted±SD, P<0.05) and deteriorates from T1 to T2: 17.8±2.1–15.1±2.4, P<0.001 (76.1±14.9–64.6±15.5, P<0.05),
revertingtoasimilarvaluetothatatT0,whileinGroupSpeakVO didnotchangefromT0toT1andsignificantlydeterioratesfromT1to
2
T2:14.5±1.2–11.4±1.2ml/kg/min±SD,P<0.00001(60.6±8.4–47.4±6.9%predicted±SD,P<0.00001).
CONCLUSIONS:PRPwasavalidpreoperativestrategytoimprovephysicalperformanceinpatientswithbothNSCLCandCOPDandthis
advantagewasalsomaintainedaftersurgery.
Keywords:Lungcancer(cid:129)Chronicobstructivepulmonarydisease(cid:129)Preoperativeriskassessment(cid:129)Rehabilitation(cid:129)VO
2max
INTRODUCTION Respiratory Society (ERS) and the European Society of Thoracic
Surgery(ESTS)[8]stronglyrecommendedtheevaluationofpatients’
Respiratory function has always been considered crucial for pre- physicalperformance.Theseguidelinessuggesttheextensiveuseof
operative evaluation of patients with non-small-cell lung cancer VO peakevaluationbymeansofCPETeveninthepresenceofa
2
(NSCLC). On the other hand, despite improvements in surgical slightfunctionalalterationdetectedbybasaltests(forcedexpiratory
techniques and perioperative care, the reduction of respiratory volumeinonesecond(FEV1)and/ordiffusionlungcapacityofCO
function after surgery is inevitable. Therefore, the preoperative (DLCO)<80%ofthepredictedvalue).Indeed,theVO peak,which
2
evaluationofrespiratorylungfunctionisoneofthemostimport- isanindicatorofphysicalperformance,hasprovedtobethebest
ant factors to determine operability, particularly in patients with independent predictor of the surgical complication rate [9].
chronicobstructivepulmonarydisease(COPD)[1–4]. IncreasingtheVO peakvalueandthepatient’stolerancetoexer-
2
Until 2007, surgical candidates with NSCLC were evaluated ciseshouldbethemostimportantpreoperativegoal.Thelattercan
accordingtotheguidelinesoftheBritishThoracicSociety[5],and beachievedbymeansofoptimalmedicaltreatmentandrehabilita-
therecommendationsoftheAmericanCollegeofChestPhysicians tion,whichshouldbothbeusedtoaddtotheirsynergicbeneficial
[6,7].Cardiopulmonary exercise test (CPET) was performed only effects. It has long been known that preoperative respiratory re-
in selected cases. More recently, the guidelines of the European habilitationamelioratesthe physical performanceofpatients with
©TheAuthor2013.PublishedbyOxfordUniversityPressonbehalfoftheEuropeanAssociationforCardio-ThoracicSurgery.Allrightsreserved.
COPD [10].Similarly, the possibilityof reducing the perception of secondgroup(surgery,S) didnotparticipateinthepreoperative
dyspnoeaandincreasingexercisetoleranceandqualityoflife(the PRPandunderwentonlysurgeryaccordingtothenormalstand-
impactofmorbidityandmortalityhasyettobedefined)inpatients ardpreoperativeprotocol.
with emphysema undergoing lung volume reduction surgery has Allpatientshadabaselineevaluationatthetimeofenrolment
beenrecognized[11,12].Instead,onlyafewstudiesevaluatedthe inthestudy(T0),anintermediateevaluation(T1)attheendofthe
effects of preoperative respiratory rehabilitation in patients with PRP for Group R and immediately before surgery for Group S,
bothCOPDandNSCLC[13–15]. respectively.Thefinalevaluation(T2)wasperformed60daysafter
Theaimofthisstudywastheevaluationoftheeffectsofapre- lobectomy for both groups. We studied: respiratory function, by
operativepulmonaryrehabilitationprogram(PRP)onpeakVO as meansofFEV1,FVCandDLCO;dyspnoeabymeansofBorgscale;
2
measure of physical performance in a group of COPD patients physicalperformancebymeansofCPETpeakVO measure.
2
with NSCLC undergoing lobectomy. The secondary goal wasthe
evaluation of the postoperative impact of PRP on physical per-
formanceupto60daysaftersurgery. Pulmonaryrehabilitationprogram
ThePRPwasdividedinto153-hsessions,fromMondaytoFriday,
MATERIALANDMETHODS for3weeks.Theprogrammeconsistedofrespiratoryexerciseson
thebench,mattresspadandwallbars,respectively,followedbya
Patients highintensitytrainingoftheupperlimbswiththerowingergom-
eterandthelowerlimbsbymeansofthetreadmillandtheergo-
FortyCOPDpatients(23males—17females;age65±7years)with metric bicycle. The exercise work load for each patient was set
a Stage I/II NSCLC undergoing lobectomy were enrolled in the according to the results of the CPET, starting with 70% of the
study from February 2010 until December 2011. The criteria for maximum score reached at the CPET and increased by 10W
operability and resectability were based on the preoperative whenthepatientwasabletotoleratethesetloadfor30min.
stagingtestandtherecommendationsoftheERS/ESTSguidelines
[8]. The lobectomy was performed by means of open thoracot-
omy.Allpatientssignedinformedconsentbeforeenrollinginthe Cardiopulmonaryexercisetestandevaluation
study.Allthepatientsenrolledinthestudyweretreatedwithlong- ofdyspnoea
term bronchodilators (beta-2 agonists and/or anticholinergic) or
withanassociationofbeta-2agonists/inhaledcorticosteroids;the
CPET was performed at T0, T1 and T2 by means of the loading
therapy was not modified at the enrolment and remained un-
ramptestwiththeergometricbicycle(ergolineergoselect,Sensor
changedfortheperiodofthestudyinordernottoinfluencethe
Medics, Milan, Italy) connected to computerized analyser V
max
resultsofthePRP.ThepatientsinGroupSwereexcludedfromthe
encore 29c (Sensor Medics, Milan, Italy), with the breath-by-
PRP,despitetheevidenceofafavourableeffectonpostoperative
breathmethod.Inbrief,thepatientwasmonitoredmeasuringthe
morbidityandmortality,becausetheywerewithintheoperability
bloodpressureevery2min;theSO bymeansofpulseoximeter;
2
criteria.
continuous 12 lead EKG; exhaled gas O and CO breath-by-
2 2
TheinclusionandexclusioncriteriaarelistedinTable1.
breathatthemouthofthepatient.Theteststartedwitha2min
evaluation of the patient at rest followed by a warm-up period
duringwhichthepatientcycledfreelyfor2min.Then,theinten-
Studydesign sityofthecyclingwasincreasedwithramploadingofthepreset
watts,lasting8–10minuntiltheendofthetest.Theloadingramp
Patients were randomly assigned to two groups. The patients in wasplannedaccordingtothepredictedpatientworkloadresult-
thefirstgroup(rehabilitation,R)underwenta3-weekpreoperative ingfrompatient’s age,sex,weight,anddietbesidesthegradeof
outpatientintensivePRPbasedonhigh-intensitytrainingofboth obstruction diagnosed at spirometry. The CPET was interrupted
upper- and lower-limb muscles. Conversely, the patients in the whenthepatientreachedthemaximumpredictedcardiacrateor
theoccurrenceofotherkindsoflimitations.Attheendofthetest,
the grade of dyspnoea was measured with the BORG scale. The
maximum consumption of O at exercise peak (VO peak) was
2 2
Table1: Inclusionandexclusioncriteria recorded measuring the absolute value expressed in ml/kg/min
andthepercentageofthepredictedvalues.
Inclusioncriteria
Maleorfemale
Age<75years Respiratoryfunctiontests
DiagnosisofNSCLCstageI–IIA
ConcomitantdiagnosisofCOPDaccordingtotheGOLDguidelines
Exclusioncriteria Therespiratoryfunctiontestswereperformedusingaplethysmo-
Diabetes graph box (V6200 Autobox, Sensor Medics, Milan, Italy) con-
Cardiovasculardisease nectedtoadryspirometer(V 22,SensorMedics,Milan,Italy).
Chronicrenalfailure max
The spirometer was interfaced with a computer equipped with
Liverfailure
Respiratoryfailure(PaO <60mmHg,breathingroomairatrest) the specific software for the analysis of respiratory function tests
2
SpO <90%duringthe6-minwalkingtest (V , Sensor Medics Milan, Italy). All respiratory function tests
2 max
BMI>30 and measurements were performed according to American
Thoracic and European Respiratory Societies [7]. FEV1, FVC, and
CICAROHT
F.Stefanellietal./EuropeanJournalofCardio-ThoracicSurgery e261
e262 F.Stefanellietal./EuropeanJournalofCardio-ThoracicSurgery
FEV1/FVCratiowereallexpressedasabsolute(ml)andpercentage Intragroupanalysis:GroupS
values according to predicted values for age, sex, weight and
heightofthepatients.DiffusionlungofCOwasexpressedasml/ PeakVO didnotchangefromT0toT1andsignificantlydeterio-
2
mmHg/min. rated after surgery: peak VO , ml/kg/min±SD (% predicted
2
value±SD),T0vsT1:14.8±1.4vs14.5±1.2,P=NS(60.8±8.7vs
60.6±8.4, P=NS), T1 vs T2: 14.5±1.2 vs 11.4±1.2, P<0.00001
(60.6±8.4 vs 47.4±6.9, P<0.00001), Fig. 4, Table 3. Dyspnoea,
Statisticalanalysis
The inter-groups analysis was performed at T0, T1 and T2 by a
t-test for independent sampleswhile theintragroup analysis was
performedbyat-testfordependentsamplesforallthedifferent
parameters evaluated at T0, T1 and T2: comparisons were per-
formed between T0 and T1, T0 and T2 and T1 and T2 and a
P-valueof<0.05wasconsideredstatisticallysignificant.
RESULTS
Inter-groupcomparisons
At T0, the two groups did not significantly differ in age
(years±SD, Group R vs S: 65.5±7.4 vs 64.8±7.3, P=NS), BMI
(GroupRvsS:25.6±4.5vs27.6±3.5,P=NS),FEV1andpeakVO
2
(Table2).
No difference between groups was observed in pulmonary
Figure1:Inter-groupcomparisonatT1:VO%predictedvalues.
function,bymeansFEV1,alsoatT1andT2(Table2),whileasig- 2
nificantdifferencewasevidentinpeakVO valueafterPRPatT1:
2
[GroupRvsSpeakVO ,ml/kg/min±SD(%predictedvalue±SD):
2
17.8±2.1 vs 14.5±1.2 (76.1±14.9 vs 60.6±8.4), P<0.0001
(<0.05),Fig.1,Table2]andthisdifferencewasmaintainedalso60
daysaftersurgeryatT2:[peakVO ,ml/kg/min±SD(%predicted
2
value±SD): 15.1±2.4 vs 11.4±1.2 (64.6±15.5 vs 47.4±6.9),
P<0.05(<0.05),Fig.2,Table2].
Intragroupanalysis:GroupR
PeakVO improvedsignificantlyafterPRPandsignificantlydete-
2
rioratedaftersurgery,goingbacktoasimilarvaluetothatatbase-
line:peakVO ,ml/kg/min±SD(%predictedvalue±SD),T0vsT1:
2
14.9±2.3vs17.8±2.1,P<0.001(64.5±16.5–76.1±14.9,P<0.05);
T1 vs T2: 17.8±2.1–15.1±2.4, P<0.001 (76.1±14.9–64.6±15.5,
P<0.05), Fig. 3, Table 3. Dyspnoea, measured by the modified
BORGscale andrespiratoryfunctiondidnotchangesignificantly
afterPRPanddeterioratedsignificantlyaftersurgery(Table3).
Figure2:Inter-groupcomparisonatT2:VO%predictedvalue.
2
Table2: Inter-groupcomparisonforrespiratoryfunctionandphysicalperformanceatbaseline(T0),T1andT2
T0 T1 T2
GroupR GroupS P-value* GroupR GroupS P-value* GroupR GroupS P*
FEV1%predicted 57.4±19.1 57.6±16.9 NS 59.8±19.2 57.5±17.0 NS 44.1±17.5 46.4±15.5 NS
VO ml/kg/min%predicted 14.9±2.3 14.8±1.4 NS 17.8±2.1 14.5±1.2 <0.001 15.1±2.4 11.4±1.2^ <0.01
2
64.5±16.5 60.8±8.7 NS 76.1±14.9 60.6±8.4 <0.05 64.6±15.5 47.4±6.9* <0.05
*Thet-testforindependentsamples.
Table3: Intragroupanalysis,GroupR:respiratoryfunction,dyspnoeaandphysicalperformance
GroupR GroupS
T0 T1 T2 T0 T1 T2
FEV1ml±SD(%predictedvalue±SD) 1519±770 1728±790 1296±790* 1462±325 1465±336 1153±280*
57.4±19.1 59.8±19.2 44.1±17.5* 57.6±16.9 57.5±17.0 46.4±15.5*
DLCOml/min/mmHg/±SD 16.0±4.8 16.3±4.6 12.6±4.3* 15.6±2.6 15.9±2.4 12.4±2.1**
(%predictedvalue±SD) 64.0±17.6 65.3±16.4 50.2±15.2* 70.3±12.5 69.9±11.9 55.7±11.9*
BORGgrades±SD 1.7±2.2 0.9±1.0*** 2.0±1.2* 1.9±0.6 1.8±0.7 3.1±0.7*
VO ml/kg/min±SD(%predictedvalue±SD) 14.9±2.3 17.8±2.1** 15.1±2.4**** 14.8±1.4 14.5±1.2 11.4±1.2*
2
64.5±16.5 76.1±14.9** 64.6±15.5**** 60.8±8.7 60.6±8.4 47.4±6.9*
Thet-testforpaireddata,*P<0.01vsT0andT1;**P<0.01vsT0;***P<0.05vsT0and****P<0.01vsT1.
measured by the modified BORG scale and respiratory function
didnotchangesignificantlyfromT0toT1anddeterioratedsignifi-
cantlyaftersurgery(Table3).
The differences between different time points in both groups
arelistedinTable4.
DISCUSSION
Onthebasisofthedataobtained,itispossibletostatethatpre-
operativehigh-intensityPRPimprovesthedegreeofphysicalper-
formanceofpatientswithCOPDandNSCLCundergoingsurgical
resection compared with similar surgical patients who did not
undergopreoperativePRP.Thesedifferenceswerenotpresentat
thebaselineevaluationandbecameobviousafterPRP,andcon-
tinuedtobeobservedaftersurgery.Infact,thepossibilityofim-
proving the physical performance of patients with COPD by
means of preoperative PRP has long been known [16].Similarly,
preoperative PRP reduced the perception of dyspnoea and
Figure 3: Intragroup analysis at different time points in Group R: VO%
2
predictedvalue. increasedbothexercisecapacityandqualityoflifeofpatientswith
pulmonary emphysema undergoing lung volume reduction
surgery,eveniftheimpactofpreoperativePRPonmorbidityand
mortalityneedstobebetterclarifiedinthissubsetofpatients[11,
12]. On the other hand, there were no data on the beneficial
effects of preoperative PRP on patients with COPD and NSCLC
undergoingsurgery.Actually,despitethescarcedatainthelitera-
ture,theresultsofourstudyshowthatpreoperativePRPisanim-
portantstrategy,togetherwithoptimizationofthepharmacological
therapy and quitting smoking, in order to improve the surgical
outcomeofthissubsetofpatients.Thisapproachseemstobeeven
morecrucialsincepreoperativePRPincreasesthenumberofthese
patientseligibleforsurgery.Inthisregard,itisimportanttounder-
line the role of CPET in risk stratification [9]. CPET is performed
accordingthecurrentERS/ESTSguidelineswhenthefirst-levelre-
spiratory functional test (FEV1 and DLCO) shows some anomalies
[8].Thistest (morethantherespiratoryfunctionaltestsperformed
with the patient at rest) measuresthe maximal oxygen consump-
tion,orpeakVO oxygen,whichrepresentsthesumoftheintegrate
2
functionsofdifferentorgansandapparatusinvolvedinthemuscu-
laroxygenation[17,18].
Theclinicalimportanceofthistestisbasedontheobservation
that the cardiorespiratory functional evaluation at rest does not
oftencorrelatewiththemaximalexercisecapabilityofthepatient.
Figure 4: Intragroup analysis at different time points in Group S: VO%
2
predictedvalue. Ontheotherhand,theevaluationofthestresstestismorereliable
CICAROHT
F.Stefanellietal./EuropeanJournalofCardio-ThoracicSurgery e263
e264 F.Stefanellietal./EuropeanJournalofCardio-ThoracicSurgery
Table4: Differencesbetweentimepoints;inGroupR,peakVO significantlyrisesfromT0toT1anddeclinesfromT1toT2ata
2
valuesimilartothatatT0whileinGroupS,peakVO doesnotchangefromT0toT1andsignificantlydeclinesfromT1toT2
2
GroupR GroupS
T1–T0 T2–T1 T2–T0 T1–T0 T2–T1 T2–T0
FEV1ml(%predictedvalue) +209 −432 −223 +3 −312 −309
+2.4 −15.7 −13.3 −0.1 −11.1 −11.2
DLCOml/min/mmHg/±SD(%predictedvalue±SD) +0.3 −3.7 −3.4 +0.3 −3.5 −3.2
+1.3 −15.1 −13.8 −0.2 −14.2 −14.4
BORGgrades±SD −0.8 +1.1 +0.3 −0.1 +1.3 +1.2
VO ml/kg/min±SD(%predictedvalue±SD) +2.9 −2.7 +0.2 −0.3 −3.1 −3.4
2
+11.6 −11.5 +0.1 −0.2 −13.2 −13.6
than the functional respiratory tests at rest like spirometry and Funding
echocardiography. The results of this study clearly demonstrated
thecentralroleofCPETinthepreoperativeevaluationofpatients Conflictofinterest:nonedeclared.
withCOPDandNSCLC,accordingtoERS/ESTSguidelines.
Inthelast10years,complexalgorithmsandbetterpredictorsof
perioperative and/or postoperative complications have been
developedwiththeobjectiveofimprovingtheriskstratificationof REFERENCES
patients with NSCLC eligible for surgery. The results of a large
meta-analysis published in 2007 showed that there is an inverse
[1] DamhuisRAM,SchüttePR.Resectionratesandpostoperativemortalityin
relationship between the perioperative and/or postoperative 7,899patientswithlungcancer.EurRespirJ1996;9:7–10.
complicationratesandtheVO peakmeasuredbymeansofcar- [2] BecklesMA,SpiroSG,ColiceGL,RuddRM.Thephysiologicevaluationof
2
diorespiratory stress test [19].Therefore, the risk stratification by patientswithlungcancerbeingconsideredforresectionalsurgery.Chest
2003;123(1Suppl):105S–14S.
means of the measurement of the physical performance has
[3] Semik M, Schmid C, Trosch F, Broermann P, Scheld HH. Lung cancer
become crucial to the point that the ERS/ESTS Task Force con- surgery—preoperativeriskassessmentandpatientselection.LungCancer
cluded that the exercise capability has a reverse correlation with 2001;33(Suppl1):S9–S15.
the postoperative complications rate (Grade 1+) [8]. Other tests [4] Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD.
COPDprevalenceisincreasedinlungcancer,independentofage,sexand
used for the evaluation of the physical performance, like the
smokinghistory.EurRespirJ2009;34:380–6.
6-minwalkingtest,theshuttlewalkingtest,andthestair-climbing
[5] Guidelines on the selection of patients with lung cancer for surgery.
test have proved to be less reliable with respect to CPET, which BritishThoracicSocietyandSocietyofCardiothoracicSurgeonsofGreat
shouldthenbeconsideredthegoldstandard[20,21].Theshuttle BritainandIrelandWorkingParty.Thorax2001;56:89–108.
walkingtestcorrelatesonlypartiallywiththeVO values.Patients [6] ColiceLG,ShafazandS,GriffinJP,KeenanR,BolligerCT.Physiologicevalu-
2 ation of the patient with lung cancer being considered for resectional
withlungcancereligibleforsurgerywhoareunabletowalk<250 surgery.Chest2007;132(3Suppl):161S–77S.
montwodifferentoccasionsareconsideredathighriskforboth [7] ATS/ACCP Statement on cardiopulmonaryexercise testing. Am J Respir
perioperative and/or postoperative complications and mortality CritCareMed2003;167:211–77.
sincetheestimatedVO is<10ml/kg/min[22,23]. [8] BrunelliA,CharlouxA,BolligerCT,RoccoG,SculierJ-P,VarelaGetal.on
2
behalf of the European Respiratory Society and European Society of
Inthestairclimbingtestthepatientclimbsoneormoreramps
ThoracicSurgeonsjointtaskforceonfitnessforradicaltherapy.ERS/ESTS
of stairs. This test has proved to be the best alternative to CPET clinicalguidelines on fitness forradical therapy inlung cancer patients
since it is a good predictor of both perioperative and/or post- (surgeryandchemo-radiotherapy).EurRespirJ2009;34:17–41.
operativecomplications.Thosepatientswhoareabletoclimbfive [9] JonesLW,EvesND,HayowskyM,JoyAA,DouglasPS.Cardiorespiratory
flights of stairs are good surgical candidates since the estimated exercisetestinginclinicaloncologyresearch:systematicreviewandprac-
ticerecommendations.LancetOncol2008;9:757–65.
valueofVO willbe>20ml/kg/min.However,thistesthassome
2 [10] Moy ML, Ingenito EP, Mentzer SJ, Evans RB, Reilly JJ Jr. Health-related
limitations which affect its reproducibility and repeatability quality of life improves following pulmonary rehabilitation and lung
(heightandnumbersofsteps,speedofclimbingetc)[22–25].The volumereductionsurgery.Chest1999;115:383–9.
studieswhichusedthe6-minwalkingtestdidnotshowunivocal [11] National Emphysema Treatment Trial Research Group. Rationale and
designoftheNationalEmphysemaTreatmentTrial(NETT):aprospective
results and therefore this is not recommended for patients with
randomized trial of lung volume reduction surgery. Chest 1999;116:
NSCLCwhoaresurgicalcandidates[24]. 1750–61.
The results of this study highlighted that the beneficial effects [12] JonesLW,EvesND,PetersonBL,GarstJ,CrawfordJ,WestMJetal.Safety
obtained by means of a high-intensity preoperative RPP persist and feasibility of aerobic training on cardiopulmonary function and
evenaftersurgery:thosepatientswhounderwentpreoperativere- qualityoflifeinpostsurgicalnon-smallcelllungcancerpatients:Apilot
study.Cancer2008;113:3430–9.
spiratory rehabilitation had a better physical performance with
[13] JonesLW,PeddleCJ,EvesND,HaykowskyMJ,CourneyaKS,MackeyJR
respecttothegroupofpatientswhodidnotundergopreopera- etal.Effects ofpresurgical exercise training on cardiorespiratoryfitness
tive PRP on both pre- and post-surgical evaluation. Currently, amongpatientsundergoingthoracicsurgeryformalignantlunglesions.
other studies are needed to demonstrate that the patients who
Cancer2007;110:590–8.
[14] BobbioA,ChettaA,AmpolliniL,RimomoGL,InternulloE,CarbognaniP
undergo preoperative PRP could have also a better quality of
etal.Preoperativepulmonaryrehabilitationinpatientsundergoinglung
life, less postoperative complications and a longer survival after
resectionfornon-smallcelllungcancer.EurJCardiothoracSurg2008;33:
surgery. 95–8.
[15] Global strategy for the Diagnosis, Management, and Prevention of [21] Swinburn CR, Wakefield JM, Jones WP. Performance, ventilation, and
COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) oxygenconsumptioninthreedifferenttypesofexercisetestinpatients
2010.http://www.goldcopd.org(15April2012,datelastaccessed). withchronicobstructivelungdisease.Thorax1985;40:581–6.
[16] Casaburi R, ZuWallack R. Pulmonary rehabilitation for management of [22] BrunelliA,RefaiM,XiuméF,SalatiM,SciarraV,SocciLetal.Performance
chronicobstructivepulmonarydisease.NEnglJMed2009;360:1329–35. atsymptomlimitedstair-climbingtestisassociatedwithincreasedcardio-
[17] Jones LW, Eves ND, Mackey JR, Peddle CJ, Haykowsky M, Joy AA et al. pulmonarycomplications,mortality,andcostsaftermajorlungresection.
Safetyandfeasibilityofcardiopulmonaryexercisetestinginpatientswith AnnThoracSurg2008;86:240–7.
advancedcancer.LungCancer2007;55:225–32. [23] BolligerCT,JordanP,SolèrM,StulzP,GrädelE,SkarvanKetal.Exercise
[18] JonesLW,EvesND,HaykowskyM,JoyAA,DouglasPS.Cardiorespiratory capacityasapredictorofpostoperativecomplicationsinlungresection
exercisetestinginclinicaloncologyresearch:systematicreviewandprac- candidates.AmJRespirCritCareMed1995;151:1472–80.
ticerecommendations.LancetOncol2008;9:757–65. [24] HoldenDA,RiceTW,StelmachK,MeekerDP.Exercisetesting,6-minwalk,
[19] BenzoR,KelleyGA,RecchiL,HofmanA,SciurbaF.Complicationsoflung andstairclimbintheevaluationofpatientsathighriskforpulmonary
resectionandexercisecapacity:ameta-analysis.RespirMed2007;101:1790–97. resection.Chest1992;102:1774–9.
[20] SinghSJ,MorganMD,HardmanAE,RoweC,BardsleyPA.Comparisonof [25] Win T, Jackson A, Groves AM, Sharples LD, Charman SC, Laroche CM.
oxygen uptake during a conventional treadmill test and the shuttle Comparisonofshuttlewalkwithmeasuredpeakoxygenconsumptionin
walkingtestinchronicairflowlimitation.EurRespirJ1994;7:2016–20. patientswithoperablelungcancer.Thorax2006;61:57–60.
CICAROHT
F.Stefanellietal./EuropeanJournalofCardio-ThoracicSurgery e265
